Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Celecoxib Capsule 200 mg vs CELEBREX CAPSULE 200 MG in healthy Thai volunteers (fasting)
TCTR20190306002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib in pain, osteoarthritis (OA) and rheumatoid arthritis (RA) (2 arms), sponsored by Bio-innova. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
celecoxib
03
Conditions
painosteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on TCTR20190306002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190306002.